| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/1996 | US5491063 Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
| 02/13/1996 | US5491060 Mutant strain of E. coli for detection of methyltransferase clones |
| 02/09/1996 | CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis |
| 02/08/1996 | WO1996003649A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 02/08/1996 | WO1996003529A1 High throughput screening method for sequences or genetic alterations in nucleic acids |
| 02/08/1996 | WO1996003527A2 Diagnostic method and probe |
| 02/08/1996 | WO1996003526A1 Nucleic acid amplification method using a modified nucleoside, and detection of the amplification product using antibodies |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003521A1 Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| 02/08/1996 | WO1996003520A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003517A1 Process for preparing viruses and viral vectors |
| 02/08/1996 | WO1996003516A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003514A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | WO1996003513A2 Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
| 02/08/1996 | WO1996003512A1 Calcium independent cytosolic phospholipase a2/b enzymes |
| 02/08/1996 | WO1996003511A2 Method for producing fatty acids or derivatives thereof from oil plants |
| 02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | WO1996003509A2 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | WO1996003508A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | WO1996003507A1 Method of isolating attenuated virus and vaccine thereof |
| 02/08/1996 | WO1996003506A2 Analog of haemophilus hin47 with reduced protease activity |
| 02/08/1996 | WO1996003505A1 HARD AND SOFT WHEAT THIOREDOXINS h, HOMOLOGOUS PROTEINS, DNA FRAGMENTS CODING FOR SAID PROTEINS AND METHODS FOR PREPARING SAME |
| 02/08/1996 | WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/1996 | WO1996003503A1 Process for producing urinary trypsin inhibitor and domains thereof, novel polypeptide related to the both, and process for producing the polypeptide |
| 02/08/1996 | WO1996003502A2 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003500A1 Sustance with antiviral activity |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003498A1 Purified herpes simplex virus protease and methods of purification |
| 02/08/1996 | WO1996003495A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003436A2 EQUINE η-INTERFERON |
| 02/08/1996 | WO1996003434A1 Megakaryocyte differentiation/proliferation factor |
| 02/08/1996 | WO1996003433A1 New process for the production of biologically active protein |
| 02/08/1996 | WO1996003416A1 Nucleic acids encoding receptors for bombesin-like peptides |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003414A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 02/08/1996 | WO1996003152A1 Antisense oligonucleotides against hepatitis b viral replication |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003146A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | WO1996003144A1 Polyepitope vaccines |
| 02/08/1996 | WO1996003051A1 Production of collagen in the milk of transgenic mammals |
| 02/08/1996 | WO1996003048A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | WO1996003034A1 Method for retroviral vector insertion in fish |
| 02/08/1996 | WO1995034657A3 Microbial production of 4-, 5-, 6- and 7-substituted indole and tryptophan analogs via fermentation |
| 02/08/1996 | WO1995033851A3 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4427221A1 Retrovirus-induzierte Osteoklasten-Modulation für die Osteoporose-Therapie Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 02/08/1996 | DE4427219A1 Nukleinsäure zur Initiation der Aktivität von RNase H bzw. reverser Transkriptase Nucleic acid for initiation of the activity of RNase H and reverse transcriptase |
| 02/08/1996 | DE4418936A1 Polypeptid Polypeptide |
| 02/08/1996 | DE4192335C2 New T-cell epitope(s) derived from the TraT protein of E.Coli |
| 02/08/1996 | CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2196044A1 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | CA2195969A1 Mixtures of genetically modified insect viruses with chemical and biological insecticides for enhanced insect control |
| 02/08/1996 | CA2195880A1 High throughput screening method for sequences or genetic alterations in nucleic acids |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195804A1 Novel topoisomerase iv, corresponding nucleotide sequences and uses thereof |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195786A1 Isoamylase gene from flaviobacterium sp., compositions containing it andmethods using it |
| 02/08/1996 | CA2195678A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 02/08/1996 | CA2195669A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | CA2195642A1 Polyepitope vaccines |
| 02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
| 02/08/1996 | CA2195560A1 Method for producing fatty acids or derivatives thereof from oil plants |
| 02/08/1996 | CA2195539A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | CA2195480A1 Nucleic acid amplification method using a modified nucleoside, and detection of the amplification product using antibodies |
| 02/08/1996 | CA2195404A1 Diagnostic method and probe |
| 02/08/1996 | CA2195309A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | CA2194578A1 New process for the production of biologically active protein |
| 02/08/1996 | CA2194465A1 Process for preparing viruses and viral vectors |
| 02/08/1996 | CA2193851A1 Purified herpes simplex virus protease and methods of purification |
| 02/07/1996 | EP0695941A2 Method and apparatus for packaging a chip |
| 02/07/1996 | EP0695804A2 Recombinant enzyme for converting maltose into trehalose |
| 02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
| 02/07/1996 | EP0695802A2 Human CRH receptor-related receptor |
| 02/07/1996 | EP0695368A1 Random chemistry for the generation of new compounds |
| 02/07/1996 | EP0695367A1 Ligase chain reaction with endonuclease iv correction and contamination control |
| 02/07/1996 | EP0695361A1 Expression of heterologous genes according to a targeted expression profile |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695359A1 A method for enhancing the production of biologically active recombinant proteins |
| 02/07/1996 | EP0695358A1 Recombinant antigens from mumps virus and their use in vaccines |
| 02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
| 02/07/1996 | EP0695356A1 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695354A1 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-$g(b) (TGF-$g(b)) |
| 02/07/1996 | EP0695353A1 Selecting genes encoding catalytic antibodies |
| 02/07/1996 | EP0695352A1 Dna encoding cobra c3, cvf1, and cvf2 |
| 02/07/1996 | EP0695351A1 Isolation, selection and propagation of animal transgenic stem cells |
| 02/07/1996 | EP0695349A1 Enzymes with xylanase activity from aspergillus aculeatus |
| 02/07/1996 | EP0695348A1 Lipase variants |
| 02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |